Friday, 03 April 2020

Generics News

  • Sun Pharma generic testosterone injection gets FDA nod

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 06 Jun, 2013

    Mumbai: Sun Pharmaceutical Industries received final approval from the US FDA for its abbreviated new drug application (ANDA) for Testosterone Cypionate injection, 100 mg/ml and 200mg/ml, w...Read more

  • GlobalData: New Zealand focuses on generics

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 27 Feb, 2013

    Singapore: A new study by GlobalData has revealed that New Zealand's Pharmaceutical Management Agency's (PHARMAC) is emphasising on generics, despite the disproportionate growth in elderly ...Read more

  • Lilly expands partnership with Novast

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2012

    Singapore: In support of its commitment to maximize growth opportunities in China, Eli Lilly has decided to increase its network of manufacturing capabilities in this key emerging market co...Read more

  • Gulf nations woo Indian generic firms

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Apr, 2013

    Singapore: A new report by investment bank Alpen Capital titled, 'The GCC pharmaceutical Outlook', a number of Gulf Cooperation Council (GCC) countries are seeking investments from Indian p...Read more

  • Japan's Meiji Seika Pharma buys Medreich

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 27 Jun, 2014

    Singapore: Japan's Meiji Seika Pharma is set to acquire Bangalore-based generic drug maker Medreich for $290 million. The nine-decade-old company has acquired a 75 percent stake held by Med...Read more

  • China cracks the whip on big pharma

    Generics |  Opinion | By BioSpectrum Bureau  | 0 Comment | 02 Jun, 2014

    Two separate but equally important developments took place in China this month. One, intensification of investigations into the country's pharma and healthcare market and the other, crackdo...Read more

  • Mylan to produce generic of Gilead's HIV drug

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 03 Aug, 2012

    Singapore: Mylan signed a new agreement between its subsidiary Mylan Laboratories and Gilead Sciences. According top this agreement, Mylan licensed the rights to produce and market generic ...Read more

  • Actavis to sell generic AstraZeneca's Crestor

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 26 Mar, 2013

    Singapore: US-based Actavis reached a settlement agreement with AstraZeneca resolving outstanding patent litigation related to Actavis' generic version of rosuvastatin calcium 5, 10, 20 and...Read more

  • Pfizer, GSK sign productivity pact with Singapore's A*Star

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Pharma industry leaders Pfizer and GlaxoSmithKline have joined hands with global engineering giants Siemens together, to sign a productivity pact as founding members of a new con...Read more

  • HIV generics to take over antivirals market

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2012

    Singapore: Generics are predicted to take over the antiviral drugs market, especially in the case of HIV medication, as a series of patent expiries will open opportunities for ambitious com...Read more

  • Fujifilm, Dr Reddy's terminate generics JV

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    Hyderabad: Fujifilm and Dr Reddy's Laboratories have decided to terminate the memorandum of understanding (MoU) to enter into an exclusive partnership in the generic drugs business for the ...Read more

  • Dr Reddy's launches generic fracture drug

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 07 Mar, 2013

    Hyderabad: Dr Reddy's Laboratories (DRL) launched Zoledronic Acid Injection (4 mg/5 mL), a bioequivalent generic version of Novartis' Zometa (zoledronic acid) 4 mg/5 mL Injection in the US...Read more

  • GSK executives confessed to bribery charges: China

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 12 Jul, 2013

    Singapore: Two weeks after intense investigations into GlaxoSmithKline's (GSK) operations across China, the country's security ministry has said that those involved have confessed to 'serio...Read more

  • Ranbaxy to market Desvenlafaxine in the US

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 06 Mar, 2013

    Bangalore: Ranbaxy Pharmaceuticals, a wholly owned subsidiary of Ranbaxy Laboratories, has entered into an in-licensing agreement with Alembic Pharmaceuticals to exclusively market Desvenl...Read more

  • India to review its pharma FDI policies

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2013

    New Delhi: The Indian government will be reviewing the foreign direct investment (FDI) policies for the pharmaceutical industry in the country at the end of the month in a high level meetin...Read more

  • DCGI nod for Zydus Cadila diabetic dyslipidemeia drug

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jun, 2013

    Singapore: Days after the Drug Controller General of India (DCGI) approved Cadila Healthcare's new chemical entity, Lipaglyn, for launch in India, the company announced its plans for the ye...Read more

  • Gilead, Teva to settle patent case of HIV drug

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 21 Feb, 2013

    Singapore: Biopharmaceutical companies Gilead Sciences and Teva Pharmaceuticals have decided to settle the ongoing patent litigation concerning the patents protecting Viread (tenofovir diso...Read more

  • Police: Sexual favours spurred GSK's $1.5 bn China sales

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jul, 2013

    Singapore: A day after making the allegations against GlaxoSmithKline's senior executives public, China's Public Security Ministry has said that bribes paid to hospitals, health officials a...Read more